SSTR2 and nasopharyngeal carcinoma: In a clinical trial of NPC patients (NCT03670342) we show the use of SSTR2 as a potential noninvasive biomarker in NPC and integrated SSTR2 protein expression data with 68Ga-DOTA-peptide imaging data on 12 patients.